Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GCFC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ETAA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PAK2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RPAIN - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SYNRG - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CCDC88A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
S100PBP - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CFLAR - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATAD2B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SFT2D2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TIA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CASC7 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SH3GLB1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MDM4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MFN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CEPT1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FGFR2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NCOA6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CEP63 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on